Authors:
Qiu, CB
Qiu, CS
Hess, P
Clozel, JP
Clozel, M
Citation: Cb. Qiu et al., Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure, ACT PHAR SI, 22(6), 2001, pp. 541-548
Authors:
Oefner, C
Binggeli, A
Breu, V
Bur, D
Clozel, JP
D'Arcy, A
Dorn, A
Fischli, W
Gruninger, F
Guller, R
Hirth, G
Marki, HP
Mathews, S
Muller, M
Ridley, RG
Stadler, H
Vieira, E
Wilhelm, M
Winkler, FK
Wostl, W
Citation: C. Oefner et al., Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?, CHEM BIOL, 6(3), 1999, pp. 127-131
Authors:
Karam, H
Clozel, JP
Bruneval, P
Gonzalez, MF
Menard, J
Citation: H. Karam et al., Contrasting effects of selective T- and L-type calcium channel blockade onglomerular damage in DOCA hypertensive rats, HYPERTENSIO, 34(4), 1999, pp. 673-678
Authors:
Clozel, JP
Veniant, MM
Qiu, CB
Sprecher, U
Wolfgang, R
Fischli, W
Citation: Jp. Clozel et al., Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure, J CARDIO PH, 34(5), 1999, pp. 674-682
Authors:
Roux, S
Qiu, CB
Sprecher, U
Osterwalder, R
Clozel, JP
Citation: S. Roux et al., Protective effects of endothelin receptor antagonists in dogs with aortic cross-clamping, J CARDIO PH, 34(2), 1999, pp. 199-205
Authors:
Clozel, M
Qiu, CB
Osterwalder, R
Roeckel, A
Bruneval, P
Heudes, D
Clozel, JP
Citation: M. Clozel et al., Effects of nonpeptide endothelin receptor antagonists in rats with reducedrenal mass, J CARDIO PH, 33(4), 1999, pp. 611-618
Authors:
Clozel, M
Ramuz, H
Clozel, JP
Breu, V
Hess, P
Loffler, BM
Coassolo, P
Roux, S
Citation: M. Clozel et al., Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use, J PHARM EXP, 290(2), 1999, pp. 840-846